Regel Therapeutics

0 followers


Combining cutting edge science, experienced business leaders and innovators, Regel Therapeutics is committed to leveraging its proprietary platform technology to revolutionize gene therapy and change patient outcomes across multiple indications.

Employees

11-50

Links

Org chart

Megan Mcgill
Interim Chief Executive Officer

Megan Mcgill

Collapse
J Epstein
Chief Scientific Officer
Jordane Dimidschstein
Co-founder And COO
Navneet Matharu
Co-founder And CSO

Teams

This company has no teams yet